105 related articles for article (PubMed ID: 30994010)
1. Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis.
Yang X; Zhang X; Lin B; Feng X; Aili A
Int J Hyperthermia; 2019; 36(1):486-492. PubMed ID: 30994010
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.
Zhao TT; Pang LL; Yang LL; Li RN; Fan LX; Wen Y
Arch Gynecol Obstet; 2023 Aug; 308(2):351-362. PubMed ID: 35947146
[TBL] [Abstract][Full Text] [Related]
3. Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis.
Guo W; Lin Y; Hu S; Shen Y
Clin Ther; 2023 Oct; 45(10):973-976. PubMed ID: 37599165
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and Effectiveness of Hysteroscopic Suture Fixation of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Adenomyosis.
Lv N; Guo J; Yuan Q; Shen S; Chen Q; Tong J
J Minim Invasive Gynecol; 2024 Jan; 31(1):57-63. PubMed ID: 37838016
[TBL] [Abstract][Full Text] [Related]
5. Effects of different treatment methods on clinical efficacy and fertility outcomes of patients with adenomyosis.
Chu Z; Jia L; Dai J; Wu Q; Tian F; Bai S
J Ovarian Res; 2024 Jan; 17(1):16. PubMed ID: 38216945
[TBL] [Abstract][Full Text] [Related]
6. Changes of serum CA125 and PGE2 before and after high-intensity focused ultrasound combined with GnRH-a in treatment of patients with adenomyosis.
Huang Y; Zhou Y; Chen H; Xu Y
Open Med (Wars); 2024; 19(1):20230794. PubMed ID: 38463528
[TBL] [Abstract][Full Text] [Related]
7. The suture fixation of levonorgestrel-releasing intrauterine device in the treatment of adenomyosis: A case report.
Cui H; Huang J
Int J Surg Case Rep; 2023 Sep; 110():108772. PubMed ID: 37666166
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system is effective for long-term management of adenomyosis.
Jiang J; Pan Y; Yu J; Zhang Y; Yang Y; Xu H; Sun F
BMC Womens Health; 2024 Jan; 24(1):28. PubMed ID: 38191409
[TBL] [Abstract][Full Text] [Related]
9. Analysis of related factors influencing postoperative recurrence of adenomyosis treated with HIFU.
Fan LX; Zhang Y; Yang LL; Ji XL; Wang Y; Huang YF; Shi L; Wen Y
Arch Gynecol Obstet; 2024 May; 309(5):1765-1773. PubMed ID: 38347252
[TBL] [Abstract][Full Text] [Related]
10. Current Medical Therapy for Adenomyosis: From Bench to Bedside.
Etrusco A; Barra F; Chiantera V; Ferrero S; Bogliolo S; Evangelisti G; Oral E; Pastore M; Izzotti A; Venezia R; Ceccaroni M; Laganà AS
Drugs; 2023 Nov; 83(17):1595-1611. PubMed ID: 37837497
[TBL] [Abstract][Full Text] [Related]
11. A controlled clinical trial comparing potent progestins, LNG-IUS and dienogest, for the treatment of women with adenomyosis.
Ota I; Taniguchi F; Ota Y; Nagata H; Wada I; Nakaso T; Ikebuchi A; Sato E; Azuma Y; Harada T
Reprod Med Biol; 2021 Oct; 20(4):427-434. PubMed ID: 34646070
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the efficacy of GnRH-a pretreatment before total hysterectomy for adenomyosis patients: a propensity score matching analysis].
Chen MG; Zhao ML; Fu HL; Mao M; Wang Q; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2023 Aug; 58(8):589-594. PubMed ID: 37599256
[No Abstract] [Full Text] [Related]
13. Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial.
Sharma S; RoyChoudhury S; Bhattacharya MP; Hazra S; Majhi AK; Oswal KC; Chattopadhyay R
Reprod Biomed Online; 2023 Jul; 47(1):84-93. PubMed ID: 37149412
[TBL] [Abstract][Full Text] [Related]
14. Optimized treatment parameter by computer simulation for high-intensity focused ultrasound treatment of uterine adenomyosis: Short-term and long-term results.
Bae JS; Lee JY; Chung HH; Lee M; Jeon MJ; Kim H; Kim HS; Kim K; Lee CS; Son K; Han JK
PLoS One; 2024; 19(3):e0301193. PubMed ID: 38547090
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cornual pregnancy in a patient with adenomyosis by high-intensity focused ultrasound (HIFU) ablation: A case report.
Yu L; Xu L; Xu X
Medicine (Baltimore); 2017 Dec; 96(48):e8874. PubMed ID: 29310371
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and meta-analysis of reproductive outcomes after high-intensity focused ultrasound (HIFU) treatment of adenomyosis.
Chen Y; Lin S; Xie X; Yi J; Liu X; Guo SW
Best Pract Res Clin Obstet Gynaecol; 2024 Feb; 92():102433. PubMed ID: 38065008
[TBL] [Abstract][Full Text] [Related]
17. High-intensity focused ultrasound for endometrial ablation in adenomyosis: a clinical study.
Wu S; Liu J; Liu X; Han Y
Front Med (Lausanne); 2024; 11():1332080. PubMed ID: 38576714
[TBL] [Abstract][Full Text] [Related]
18. Evolution of uterine adenomyosis volume during and after GnRH antagonist (linzagolix) treatment: lessons for further clinical trials.
Donnez J; Donnez O; Dolmans MM
Fertil Steril; 2023 Nov; 120(5):1071-1073. PubMed ID: 37495010
[No Abstract] [Full Text] [Related]
19. The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review.
Moawad G; Youssef Y; Fruscalzo A; Faysal H; Kheil M; Pirtea P; Guani B; Ayoubi JM; Feki A
J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834773
[TBL] [Abstract][Full Text] [Related]
20. [Progress on medical treatment in the management of adenomyosis].
Baboo KD; Chen Z; Zhang X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 48(2):142-147. PubMed ID: 31309751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
